Clinical Trial Update: Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI. [Phase 4]

View source ↗

Summary

An ongoing Phase 4 trial is examining whether body mass index influences the plasma exposure of the trastuzumab deruxtecan payload (Free-DXd) in patients treate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)
• Free-DXd (deruxtecan payload)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Locally Advanced or Metastatic Breast Cancers | Phase 4 | Status: RECRUITING